Improved endocervical sampling and HPV viral load detection by Cervex-Brush® Combi

Cytopathology

Volumn 17, Issue 6, 2006, Pages 374-381

  Depuydt, C E ^a   Benoy, I H ^a   Bailleul, E J ^b   Vandepitte, J ^a   Vereecken, A J ^a   Bogers, J J ^a,c  

^a Laboratory for Clinical Pathology (Labo Lokeren Campus RIATOL)   (Belgium)

^b Sint Vincentius Ziekenhuis   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cervex Brush Combi; Cervical cytology; Cervical screening; Cytodiagnosis; Cytological techniques; Diagnosis; Endocervical cell component; Laboratory diagnosis; Sampling devices; Screening programmes

Indexed keywords

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOLOGY; DEVICE; ENDOTHELIUM CELL; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SAMPLING; SCREENING; SCREENING TEST; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE ENDOCERVIX; VIRUS LOAD; VIRUS TYPING; WART VIRUS;

COHORT STUDIES; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD;

EID: 33751347063     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2006.00386.x     Document Type: Article

References (15)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No. 5. Lyon: IARC Press; 2001.
2. Davies P, Arbyn M, Dillner J et al. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer 2005;118:794-6.
3. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999;91:506-11.
4. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
5. Marchand L, Mundt M, Klein G, Agarwal SC. Optimal collection technique and devices for a quality pap smear. WMJ 2005;104:51-5.
6. Kohlberger PD, Stani J, Gitsch G, Kieback DG, Breitenecker G. Comparative evaluation of seven cell collection devices for cervical smears. Acta Cytol 1999;43:1023-6.
7. Vassilakos P, Saurel J, Rondez R. Direct-to-vial use of the autocyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories. Acta Cytol 1999;42:65-8.
8. Vassilakos P, Griffin S, Megevand E, Campana A. CytoRich liquid-based cervical cytology test: screening results in a routine cytopathology service. Acta Cytol 1998;42:198-202.
9. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
10. Sahebali S, Depuydt CE, Segers K et al. P16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer 2004;108:871-6.
11. Depuydt CE, Vereecken AJ, Salembier GM et al. Thinlayer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer 2003;88:560-6.
12. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41:3221-8.
13. Flores-Mungia R, Siegel E, Klimecki WT, Guiliano AR. Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types. J Mol Diagn 2004;6:115-24.
14. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995;48:257-62.
15. Moberg M, Gustavsson I, Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 2004;112:854-9.